Connect your AI

Clarivate CLVT 2027

2027 at other companies

ExlService HoldingsEXLS

——

Bio-Rad LaboratoriesBIO

——

Other financials

Income statement

Revenue$585.5M-1.4%

Gross profit$393.4M+1.7%

Operating income$30.2M+245%

Net income-$40.2M+61.3%

EPS (diluted)-$0.06+60.0%

Balance sheet

Cash & equivalents$242.2M-31.6%

Total debt$4.4B-5.7%

Total equity$4.8B-4.7%

Total assets$10.9B-4.9%

Cash flow

Operating cash flow$134.7M-21.3%

CapEx$55.8M-8.4%

Free cash flow$78.9M-28.5%

Valuation

Market cap$1.28B-55.2%

Enterprise value$5.45B-24.2%

P/S0.5×-0.6×

Profitability

Gross margin66.5%+0.5pp

Operating margin5%+2.9pp

Net margin-5.7%-2.5pp

FCF margin13.6%-0.4pp

Returns & leverage

Return on equity-2.9%-1.2pp

Debt / equity0.9×0.0×

Current ratio0.8×0.0×

Where this comes from

Reported directly by Clarivate in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths.

The official record: Clarivate’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clarivate's 2027.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Clarivate's 2027?: Clarivate (CLVT) reported 2027 of $3.4M in Q4 2025.